NASDAQ:FTSMFirst Trust Enhanced Short Maturity ETF Stock Price, Forecast & News

First Trust Enhanced Short Maturity ETF's stock was trading at $60.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FTSM shares have increased by 0.0% and is now trading at $60.08.
View which stocks have been most impacted by Coronavirus.

First Trust Enhanced Short Maturity ETF declared a monthly dividend on Monday, June 29th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.056 per share on Monday, July 6th. This represents a $0.67 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend is Tuesday, June 30th.
View First Trust Enhanced Short Maturity ETF's dividend history.

Press coverage about FTSM stock has trended very positive on Wednesday, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. First Trust Enhanced Short Maturity ETF earned a news impact score of 3.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about First Trust Enhanced Short Maturity ETF.

First Trust Enhanced Short Maturity ETF saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 271,800 shares, an increase of 173.7% from the February 13th total of 99,300 shares. Based on an average daily trading volume, of 981,700 shares, the short-interest ratio is presently 0.3 days.
View First Trust Enhanced Short Maturity ETF's Short Interest.

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Enhanced Short Maturity ETF investors own include Cigna (CI), First American Financial (FAF), Stellar Biotechnologies (SBOT), Abraxas Petroleum (AXAS), Anavex Life Sciences (AVXL), AngloGold Ashanti (AU), Asure Software (ASUR), argenx (ARGX), Digital Turbine (APPS) and Air Products & Chemicals (APD).

First Trust Enhanced Short Maturity ETF trades on the NASDAQ under the ticker symbol "FTSM."

First Trust Enhanced Short Maturity ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include UBS Group AG (3.80%), CWM LLC (2.57%), Raymond James Financial Services Advisors Inc. (2.04%), Raymond James & Associates (1.62%), Synovus Financial Corp (0.83%) and HighTower Advisors LLC (0.72%).

FTSM stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, CWM LLC, Synovus Financial Corp, Raymond James Financial Services Advisors Inc., Sawtooth Solutions LLC, AE Wealth Management LLC, Milestone Advisory Partners, and Barber Financial Group Inc..

FTSM stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, G&S Capital LLC, Lubar & Co. Inc, LexAurum Advisors LLC, Wedbush Securities Inc., Raymond James & Associates, HighTower Advisors LLC, and Csenge Advisory Group.

Shares of FTSM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of FTSM stock can currently be purchased for approximately $60.08.

First Trust Enhanced Short Maturity ETF has a market capitalization of $5.09 billion.